Approval · Notice of Compliance 21389 · 2018
TEGSEDI: Notice of Compliance 21389
Issued October 3, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21389
- Date
- October 3, 2018
- Company
- Akcea Therapeutics IncCarlsbad, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEGSEDI | 02481383 | Cancelled Post Market |
Medicinal ingredients
- INOTERSEN SODIUM 284 MG per 1.5ML